nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—SRC—colon cancer	0.733	1	CbGaD
Trabectedin—CYP2C9—Capecitabine—colon cancer	0.0169	0.441	CbGbCtD
Trabectedin—CYP2C9—Fluorouracil—colon cancer	0.01	0.262	CbGbCtD
Trabectedin—CYP3A4—Irinotecan—colon cancer	0.00606	0.159	CbGbCtD
Trabectedin—CYP3A4—Vincristine—colon cancer	0.0053	0.139	CbGbCtD
Trabectedin—SRC—endothelium—colon cancer	0.00312	0.121	CbGeAlD
Trabectedin—SRC—blood vessel—colon cancer	0.00287	0.111	CbGeAlD
Trabectedin—SRC—embryo—colon cancer	0.00171	0.0663	CbGeAlD
Trabectedin—SRC—epithelium—colon cancer	0.0014	0.0541	CbGeAlD
Trabectedin—SRC—smooth muscle tissue—colon cancer	0.00135	0.0522	CbGeAlD
Trabectedin—SRC—renal system—colon cancer	0.0013	0.0502	CbGeAlD
Trabectedin—PTGS1—endothelium—colon cancer	0.00116	0.045	CbGeAlD
Trabectedin—SRC—lymphoid tissue—colon cancer	0.00108	0.0417	CbGeAlD
Trabectedin—PTGS1—blood vessel—colon cancer	0.00107	0.0415	CbGeAlD
Trabectedin—SRC—digestive system—colon cancer	0.00106	0.0412	CbGeAlD
Trabectedin—SRC—liver—colon cancer	0.000793	0.0307	CbGeAlD
Trabectedin—Sepsis—Fluorouracil—colon cancer	0.000688	0.00521	CcSEcCtD
Trabectedin—Hepatic failure—Vincristine—colon cancer	0.000686	0.0052	CcSEcCtD
Trabectedin—Febrile neutropenia—Methotrexate—colon cancer	0.000685	0.00519	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Capecitabine—colon cancer	0.000609	0.00462	CcSEcCtD
Trabectedin—SRC—lymph node—colon cancer	0.000608	0.0235	CbGeAlD
Trabectedin—Dehydration—Vincristine—colon cancer	0.000573	0.00435	CcSEcCtD
Trabectedin—Blood creatinine increased—Irinotecan—colon cancer	0.000563	0.00426	CcSEcCtD
Trabectedin—CYP2C19—digestive system—colon cancer	0.000561	0.0217	CbGeAlD
Trabectedin—Dehydration—Irinotecan—colon cancer	0.000559	0.00423	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Vincristine—colon cancer	0.000555	0.00421	CcSEcCtD
Trabectedin—Pulmonary embolism—Capecitabine—colon cancer	0.000554	0.0042	CcSEcCtD
Trabectedin—Injection site reaction—Capecitabine—colon cancer	0.00055	0.00417	CcSEcCtD
Trabectedin—Hypokalaemia—Irinotecan—colon cancer	0.000547	0.00414	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.000541	0.0041	CcSEcCtD
Trabectedin—Hepatotoxicity—Methotrexate—colon cancer	0.000534	0.00405	CcSEcCtD
Trabectedin—Necrosis—Methotrexate—colon cancer	0.000525	0.00398	CcSEcCtD
Trabectedin—PTGS1—epithelium—colon cancer	0.000522	0.0202	CbGeAlD
Trabectedin—Pancytopenia—Vincristine—colon cancer	0.000506	0.00384	CcSEcCtD
Trabectedin—PTGS1—smooth muscle tissue—colon cancer	0.000503	0.0195	CbGeAlD
Trabectedin—CYP2E1—renal system—colon cancer	0.000503	0.0195	CbGeAlD
Trabectedin—Neutropenia—Vincristine—colon cancer	0.000498	0.00378	CcSEcCtD
Trabectedin—CYP2C19—vagina—colon cancer	0.000495	0.0192	CbGeAlD
Trabectedin—Neutropenia—Irinotecan—colon cancer	0.000485	0.00368	CcSEcCtD
Trabectedin—PTGS1—renal system—colon cancer	0.000484	0.0187	CbGeAlD
Trabectedin—Weight decreased—Vincristine—colon cancer	0.000482	0.00365	CcSEcCtD
Trabectedin—Sepsis—Capecitabine—colon cancer	0.000481	0.00364	CcSEcCtD
Trabectedin—Extravasation—Methotrexate—colon cancer	0.000472	0.00358	CcSEcCtD
Trabectedin—Pancytopenia—Fluorouracil—colon cancer	0.000472	0.00358	CcSEcCtD
Trabectedin—Weight decreased—Irinotecan—colon cancer	0.00047	0.00356	CcSEcCtD
Trabectedin—Stomatitis—Vincristine—colon cancer	0.000463	0.00351	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.000462	0.0035	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Methotrexate—colon cancer	0.000453	0.00344	CcSEcCtD
Trabectedin—Jaundice—Irinotecan—colon cancer	0.000451	0.00342	CcSEcCtD
Trabectedin—Stomatitis—Irinotecan—colon cancer	0.000451	0.00342	CcSEcCtD
Trabectedin—Hepatic failure—Capecitabine—colon cancer	0.000447	0.00339	CcSEcCtD
Trabectedin—Infestation—Fluorouracil—colon cancer	0.000443	0.00336	CcSEcCtD
Trabectedin—Infestation NOS—Fluorouracil—colon cancer	0.000443	0.00336	CcSEcCtD
Trabectedin—CYP2C9—digestive system—colon cancer	0.000435	0.0168	CbGeAlD
Trabectedin—Stomatitis—Fluorouracil—colon cancer	0.000432	0.00327	CcSEcCtD
Trabectedin—Connective tissue disorder—Vincristine—colon cancer	0.000419	0.00318	CcSEcCtD
Trabectedin—CYP2C19—liver—colon cancer	0.000418	0.0162	CbGeAlD
Trabectedin—Haemoglobin—Irinotecan—colon cancer	0.000418	0.00317	CcSEcCtD
Trabectedin—CYP2E1—lymphoid tissue—colon cancer	0.000417	0.0162	CbGeAlD
Trabectedin—Haemorrhage—Irinotecan—colon cancer	0.000415	0.00315	CcSEcCtD
Trabectedin—Agranulocytosis—Fluorouracil—colon cancer	0.000414	0.00314	CcSEcCtD
Trabectedin—CYP2E1—digestive system—colon cancer	0.000412	0.016	CbGeAlD
Trabectedin—Pulmonary embolism—Methotrexate—colon cancer	0.000412	0.00312	CcSEcCtD
Trabectedin—Connective tissue disorder—Irinotecan—colon cancer	0.000408	0.00309	CcSEcCtD
Trabectedin—CYP3A4—renal system—colon cancer	0.000404	0.0157	CbGeAlD
Trabectedin—Haemoglobin—Fluorouracil—colon cancer	0.0004	0.00303	CcSEcCtD
Trabectedin—CYP2D6—renal system—colon cancer	0.000398	0.0154	CbGeAlD
Trabectedin—Haemorrhage—Fluorouracil—colon cancer	0.000398	0.00302	CcSEcCtD
Trabectedin—PTGS1—digestive system—colon cancer	0.000397	0.0154	CbGeAlD
Trabectedin—Angiopathy—Vincristine—colon cancer	0.000387	0.00293	CcSEcCtD
Trabectedin—Flushing—Irinotecan—colon cancer	0.000386	0.00292	CcSEcCtD
Trabectedin—Mediastinal disorder—Vincristine—colon cancer	0.000384	0.00291	CcSEcCtD
Trabectedin—Alopecia—Vincristine—colon cancer	0.000377	0.00286	CcSEcCtD
Trabectedin—Angiopathy—Irinotecan—colon cancer	0.000377	0.00286	CcSEcCtD
Trabectedin—Blood creatinine increased—Capecitabine—colon cancer	0.000377	0.00285	CcSEcCtD
Trabectedin—Mediastinal disorder—Irinotecan—colon cancer	0.000374	0.00284	CcSEcCtD
Trabectedin—Dehydration—Capecitabine—colon cancer	0.000374	0.00283	CcSEcCtD
Trabectedin—Mental disorder—Vincristine—colon cancer	0.000374	0.00283	CcSEcCtD
Trabectedin—Alopecia—Irinotecan—colon cancer	0.000367	0.00278	CcSEcCtD
Trabectedin—Abdominal pain upper—Capecitabine—colon cancer	0.000367	0.00278	CcSEcCtD
Trabectedin—Pulmonary oedema—Methotrexate—colon cancer	0.000367	0.00278	CcSEcCtD
Trabectedin—Hypokalaemia—Capecitabine—colon cancer	0.000366	0.00277	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000362	0.00274	CcSEcCtD
Trabectedin—Back pain—Vincristine—colon cancer	0.000359	0.00272	CcSEcCtD
Trabectedin—Sepsis—Methotrexate—colon cancer	0.000358	0.00271	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000355	0.00269	CcSEcCtD
Trabectedin—Alopecia—Fluorouracil—colon cancer	0.000352	0.00267	CcSEcCtD
Trabectedin—PTGS1—vagina—colon cancer	0.000351	0.0136	CbGeAlD
Trabectedin—Back pain—Irinotecan—colon cancer	0.00035	0.00265	CcSEcCtD
Trabectedin—Anaemia—Vincristine—colon cancer	0.000343	0.0026	CcSEcCtD
Trabectedin—Anaemia—Irinotecan—colon cancer	0.000334	0.00253	CcSEcCtD
Trabectedin—Hepatic failure—Methotrexate—colon cancer	0.000333	0.00252	CcSEcCtD
Trabectedin—Leukopenia—Vincristine—colon cancer	0.000332	0.00252	CcSEcCtD
Trabectedin—CYP3A4—digestive system—colon cancer	0.000332	0.0128	CbGeAlD
Trabectedin—Pancytopenia—Capecitabine—colon cancer	0.00033	0.0025	CcSEcCtD
Trabectedin—CYP2D6—digestive system—colon cancer	0.000326	0.0126	CbGeAlD
Trabectedin—Neutropenia—Capecitabine—colon cancer	0.000325	0.00246	CcSEcCtD
Trabectedin—Syncope—Irinotecan—colon cancer	0.000324	0.00246	CcSEcCtD
Trabectedin—CYP2C9—liver—colon cancer	0.000324	0.0125	CbGeAlD
Trabectedin—Leukopenia—Irinotecan—colon cancer	0.000324	0.00245	CcSEcCtD
Trabectedin—Anaemia—Fluorouracil—colon cancer	0.00032	0.00243	CcSEcCtD
Trabectedin—Loss of consciousness—Irinotecan—colon cancer	0.000318	0.00241	CcSEcCtD
Trabectedin—Myalgia—Vincristine—colon cancer	0.000316	0.0024	CcSEcCtD
Trabectedin—Cough—Irinotecan—colon cancer	0.000316	0.00239	CcSEcCtD
Trabectedin—Weight decreased—Capecitabine—colon cancer	0.000314	0.00238	CcSEcCtD
Trabectedin—Leukopenia—Fluorouracil—colon cancer	0.00031	0.00235	CcSEcCtD
Trabectedin—Infestation NOS—Capecitabine—colon cancer	0.00031	0.00235	CcSEcCtD
Trabectedin—Infestation—Capecitabine—colon cancer	0.00031	0.00235	CcSEcCtD
Trabectedin—CYP2E1—liver—colon cancer	0.000307	0.0119	CbGeAlD
Trabectedin—Oedema—Vincristine—colon cancer	0.000303	0.0023	CcSEcCtD
Trabectedin—Jaundice—Capecitabine—colon cancer	0.000302	0.00229	CcSEcCtD
Trabectedin—Stomatitis—Capecitabine—colon cancer	0.000302	0.00229	CcSEcCtD
Trabectedin—Infection—Vincristine—colon cancer	0.000301	0.00228	CcSEcCtD
Trabectedin—Nervous system disorder—Vincristine—colon cancer	0.000297	0.00225	CcSEcCtD
Trabectedin—Thrombocytopenia—Vincristine—colon cancer	0.000297	0.00225	CcSEcCtD
Trabectedin—Oedema—Irinotecan—colon cancer	0.000295	0.00224	CcSEcCtD
Trabectedin—Myalgia—Fluorouracil—colon cancer	0.000295	0.00224	CcSEcCtD
Trabectedin—Infection—Irinotecan—colon cancer	0.000293	0.00222	CcSEcCtD
Trabectedin—Hepatobiliary disease—Capecitabine—colon cancer	0.000293	0.00222	CcSEcCtD
Trabectedin—Shock—Irinotecan—colon cancer	0.00029	0.0022	CcSEcCtD
Trabectedin—Nervous system disorder—Irinotecan—colon cancer	0.000289	0.00219	CcSEcCtD
Trabectedin—Agranulocytosis—Capecitabine—colon cancer	0.000289	0.00219	CcSEcCtD
Trabectedin—Thrombocytopenia—Irinotecan—colon cancer	0.000289	0.00219	CcSEcCtD
Trabectedin—Anorexia—Vincristine—colon cancer	0.000289	0.00219	CcSEcCtD
Trabectedin—Hypotension—Vincristine—colon cancer	0.000283	0.00215	CcSEcCtD
Trabectedin—Oedema—Fluorouracil—colon cancer	0.000283	0.00214	CcSEcCtD
Trabectedin—Anorexia—Irinotecan—colon cancer	0.000281	0.00213	CcSEcCtD
Trabectedin—Infection—Fluorouracil—colon cancer	0.000281	0.00213	CcSEcCtD
Trabectedin—Haemoglobin—Capecitabine—colon cancer	0.000279	0.00212	CcSEcCtD
Trabectedin—Haemorrhage—Capecitabine—colon cancer	0.000278	0.00211	CcSEcCtD
Trabectedin—Nervous system disorder—Fluorouracil—colon cancer	0.000277	0.0021	CcSEcCtD
Trabectedin—Thrombocytopenia—Fluorouracil—colon cancer	0.000277	0.0021	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000276	0.00209	CcSEcCtD
Trabectedin—Hypotension—Irinotecan—colon cancer	0.000276	0.00209	CcSEcCtD
Trabectedin—Insomnia—Vincristine—colon cancer	0.000274	0.00208	CcSEcCtD
Trabectedin—Oedema peripheral—Capecitabine—colon cancer	0.000274	0.00208	CcSEcCtD
Trabectedin—Connective tissue disorder—Capecitabine—colon cancer	0.000273	0.00207	CcSEcCtD
Trabectedin—Paraesthesia—Vincristine—colon cancer	0.000272	0.00206	CcSEcCtD
Trabectedin—Anorexia—Fluorouracil—colon cancer	0.000269	0.00204	CcSEcCtD
Trabectedin—Insomnia—Irinotecan—colon cancer	0.000267	0.00202	CcSEcCtD
Trabectedin—Paraesthesia—Irinotecan—colon cancer	0.000265	0.00201	CcSEcCtD
Trabectedin—Hypotension—Fluorouracil—colon cancer	0.000264	0.002	CcSEcCtD
Trabectedin—Decreased appetite—Vincristine—colon cancer	0.000263	0.002	CcSEcCtD
Trabectedin—Dyspnoea—Irinotecan—colon cancer	0.000263	0.00199	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Vincristine—colon cancer	0.000262	0.00198	CcSEcCtD
Trabectedin—Fatigue—Vincristine—colon cancer	0.000261	0.00198	CcSEcCtD
Trabectedin—Dyspepsia—Irinotecan—colon cancer	0.00026	0.00197	CcSEcCtD
Trabectedin—Constipation—Vincristine—colon cancer	0.000259	0.00196	CcSEcCtD
Trabectedin—Flushing—Capecitabine—colon cancer	0.000258	0.00196	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000258	0.00195	CcSEcCtD
Trabectedin—Decreased appetite—Irinotecan—colon cancer	0.000257	0.00194	CcSEcCtD
Trabectedin—Insomnia—Fluorouracil—colon cancer	0.000256	0.00194	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000255	0.00193	CcSEcCtD
Trabectedin—Fatigue—Irinotecan—colon cancer	0.000254	0.00193	CcSEcCtD
Trabectedin—Paraesthesia—Fluorouracil—colon cancer	0.000254	0.00192	CcSEcCtD
Trabectedin—Constipation—Irinotecan—colon cancer	0.000252	0.00191	CcSEcCtD
Trabectedin—Angiopathy—Capecitabine—colon cancer	0.000252	0.00191	CcSEcCtD
Trabectedin—Dyspnoea—Fluorouracil—colon cancer	0.000252	0.00191	CcSEcCtD
Trabectedin—Mediastinal disorder—Capecitabine—colon cancer	0.000251	0.0019	CcSEcCtD
Trabectedin—Dyspepsia—Fluorouracil—colon cancer	0.000249	0.00189	CcSEcCtD
Trabectedin—Gastrointestinal pain—Vincristine—colon cancer	0.000248	0.00188	CcSEcCtD
Trabectedin—CYP3A4—liver—colon cancer	0.000247	0.00957	CbGeAlD
Trabectedin—Decreased appetite—Fluorouracil—colon cancer	0.000246	0.00186	CcSEcCtD
Trabectedin—Alopecia—Capecitabine—colon cancer	0.000246	0.00186	CcSEcCtD
Trabectedin—Pancytopenia—Methotrexate—colon cancer	0.000246	0.00186	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000244	0.00185	CcSEcCtD
Trabectedin—Mental disorder—Capecitabine—colon cancer	0.000244	0.00185	CcSEcCtD
Trabectedin—CYP2D6—liver—colon cancer	0.000243	0.00941	CbGeAlD
Trabectedin—Malnutrition—Capecitabine—colon cancer	0.000242	0.00183	CcSEcCtD
Trabectedin—Neutropenia—Methotrexate—colon cancer	0.000242	0.00183	CcSEcCtD
Trabectedin—Gastrointestinal pain—Irinotecan—colon cancer	0.000241	0.00183	CcSEcCtD
Trabectedin—Body temperature increased—Vincristine—colon cancer	0.00024	0.00182	CcSEcCtD
Trabectedin—Abdominal pain—Vincristine—colon cancer	0.00024	0.00182	CcSEcCtD
Trabectedin—Dysgeusia—Capecitabine—colon cancer	0.000237	0.0018	CcSEcCtD
Trabectedin—Back pain—Capecitabine—colon cancer	0.000234	0.00177	CcSEcCtD
Trabectedin—Abdominal pain—Irinotecan—colon cancer	0.000233	0.00177	CcSEcCtD
Trabectedin—Body temperature increased—Irinotecan—colon cancer	0.000233	0.00177	CcSEcCtD
Trabectedin—Infestation NOS—Methotrexate—colon cancer	0.000231	0.00175	CcSEcCtD
Trabectedin—Infestation—Methotrexate—colon cancer	0.000231	0.00175	CcSEcCtD
Trabectedin—PTGS1—lymph node—colon cancer	0.000227	0.00878	CbGeAlD
Trabectedin—Stomatitis—Methotrexate—colon cancer	0.000225	0.0017	CcSEcCtD
Trabectedin—Anaemia—Capecitabine—colon cancer	0.000224	0.0017	CcSEcCtD
Trabectedin—Body temperature increased—Fluorouracil—colon cancer	0.000223	0.00169	CcSEcCtD
Trabectedin—Hypersensitivity—Vincristine—colon cancer	0.000223	0.00169	CcSEcCtD
Trabectedin—Hepatobiliary disease—Methotrexate—colon cancer	0.000218	0.00165	CcSEcCtD
Trabectedin—Hypersensitivity—Irinotecan—colon cancer	0.000217	0.00165	CcSEcCtD
Trabectedin—Asthenia—Vincristine—colon cancer	0.000217	0.00165	CcSEcCtD
Trabectedin—Syncope—Capecitabine—colon cancer	0.000217	0.00165	CcSEcCtD
Trabectedin—Leukopenia—Capecitabine—colon cancer	0.000217	0.00164	CcSEcCtD
Trabectedin—Agranulocytosis—Methotrexate—colon cancer	0.000215	0.00163	CcSEcCtD
Trabectedin—Loss of consciousness—Capecitabine—colon cancer	0.000213	0.00161	CcSEcCtD
Trabectedin—Asthenia—Irinotecan—colon cancer	0.000212	0.00161	CcSEcCtD
Trabectedin—Cough—Capecitabine—colon cancer	0.000211	0.0016	CcSEcCtD
Trabectedin—Hypersensitivity—Fluorouracil—colon cancer	0.000208	0.00158	CcSEcCtD
Trabectedin—Haemoglobin—Methotrexate—colon cancer	0.000208	0.00158	CcSEcCtD
Trabectedin—Diarrhoea—Vincristine—colon cancer	0.000207	0.00157	CcSEcCtD
Trabectedin—Haemorrhage—Methotrexate—colon cancer	0.000207	0.00157	CcSEcCtD
Trabectedin—Arthralgia—Capecitabine—colon cancer	0.000206	0.00156	CcSEcCtD
Trabectedin—Myalgia—Capecitabine—colon cancer	0.000206	0.00156	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000205	0.00155	CcSEcCtD
Trabectedin—Diarrhoea—Irinotecan—colon cancer	0.000202	0.00153	CcSEcCtD
Trabectedin—Dizziness—Vincristine—colon cancer	0.0002	0.00152	CcSEcCtD
Trabectedin—Oedema—Capecitabine—colon cancer	0.000198	0.0015	CcSEcCtD
Trabectedin—Infection—Capecitabine—colon cancer	0.000196	0.00149	CcSEcCtD
Trabectedin—Dizziness—Irinotecan—colon cancer	0.000195	0.00148	CcSEcCtD
Trabectedin—Shock—Capecitabine—colon cancer	0.000194	0.00147	CcSEcCtD
Trabectedin—Nervous system disorder—Capecitabine—colon cancer	0.000194	0.00147	CcSEcCtD
Trabectedin—Diarrhoea—Fluorouracil—colon cancer	0.000193	0.00147	CcSEcCtD
Trabectedin—Thrombocytopenia—Capecitabine—colon cancer	0.000193	0.00147	CcSEcCtD
Trabectedin—Vomiting—Vincristine—colon cancer	0.000193	0.00146	CcSEcCtD
Trabectedin—Skin disorder—Capecitabine—colon cancer	0.000192	0.00145	CcSEcCtD
Trabectedin—Rash—Vincristine—colon cancer	0.000191	0.00145	CcSEcCtD
Trabectedin—Dermatitis—Vincristine—colon cancer	0.000191	0.00145	CcSEcCtD
Trabectedin—Headache—Vincristine—colon cancer	0.00019	0.00144	CcSEcCtD
Trabectedin—Anorexia—Capecitabine—colon cancer	0.000188	0.00143	CcSEcCtD
Trabectedin—Angiopathy—Methotrexate—colon cancer	0.000188	0.00142	CcSEcCtD
Trabectedin—Vomiting—Irinotecan—colon cancer	0.000188	0.00142	CcSEcCtD
Trabectedin—Dizziness—Fluorouracil—colon cancer	0.000187	0.00142	CcSEcCtD
Trabectedin—Mediastinal disorder—Methotrexate—colon cancer	0.000187	0.00141	CcSEcCtD
Trabectedin—Rash—Irinotecan—colon cancer	0.000186	0.00141	CcSEcCtD
Trabectedin—Dermatitis—Irinotecan—colon cancer	0.000186	0.00141	CcSEcCtD
Trabectedin—Headache—Irinotecan—colon cancer	0.000185	0.0014	CcSEcCtD
Trabectedin—Hypotension—Capecitabine—colon cancer	0.000185	0.0014	CcSEcCtD
Trabectedin—Alopecia—Methotrexate—colon cancer	0.000183	0.00139	CcSEcCtD
Trabectedin—Mental disorder—Methotrexate—colon cancer	0.000181	0.00137	CcSEcCtD
Trabectedin—Malnutrition—Methotrexate—colon cancer	0.00018	0.00137	CcSEcCtD
Trabectedin—Nausea—Vincristine—colon cancer	0.00018	0.00136	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00018	0.00136	CcSEcCtD
Trabectedin—Vomiting—Fluorouracil—colon cancer	0.00018	0.00136	CcSEcCtD
Trabectedin—Insomnia—Capecitabine—colon cancer	0.000179	0.00135	CcSEcCtD
Trabectedin—Rash—Fluorouracil—colon cancer	0.000178	0.00135	CcSEcCtD
Trabectedin—Dermatitis—Fluorouracil—colon cancer	0.000178	0.00135	CcSEcCtD
Trabectedin—Paraesthesia—Capecitabine—colon cancer	0.000177	0.00134	CcSEcCtD
Trabectedin—Headache—Fluorouracil—colon cancer	0.000177	0.00134	CcSEcCtD
Trabectedin—Dysgeusia—Methotrexate—colon cancer	0.000176	0.00134	CcSEcCtD
Trabectedin—Dyspnoea—Capecitabine—colon cancer	0.000176	0.00133	CcSEcCtD
Trabectedin—Nausea—Irinotecan—colon cancer	0.000175	0.00133	CcSEcCtD
Trabectedin—Back pain—Methotrexate—colon cancer	0.000174	0.00132	CcSEcCtD
Trabectedin—Dyspepsia—Capecitabine—colon cancer	0.000174	0.00132	CcSEcCtD
Trabectedin—Decreased appetite—Capecitabine—colon cancer	0.000172	0.0013	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000171	0.00129	CcSEcCtD
Trabectedin—Fatigue—Capecitabine—colon cancer	0.00017	0.00129	CcSEcCtD
Trabectedin—Constipation—Capecitabine—colon cancer	0.000169	0.00128	CcSEcCtD
Trabectedin—Nausea—Fluorouracil—colon cancer	0.000168	0.00127	CcSEcCtD
Trabectedin—Anaemia—Methotrexate—colon cancer	0.000167	0.00126	CcSEcCtD
Trabectedin—Gastrointestinal pain—Capecitabine—colon cancer	0.000162	0.00122	CcSEcCtD
Trabectedin—Leukopenia—Methotrexate—colon cancer	0.000161	0.00122	CcSEcCtD
Trabectedin—Cough—Methotrexate—colon cancer	0.000157	0.00119	CcSEcCtD
Trabectedin—Abdominal pain—Capecitabine—colon cancer	0.000156	0.00118	CcSEcCtD
Trabectedin—Body temperature increased—Capecitabine—colon cancer	0.000156	0.00118	CcSEcCtD
Trabectedin—Myalgia—Methotrexate—colon cancer	0.000153	0.00116	CcSEcCtD
Trabectedin—Arthralgia—Methotrexate—colon cancer	0.000153	0.00116	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000152	0.00115	CcSEcCtD
Trabectedin—Infection—Methotrexate—colon cancer	0.000146	0.00111	CcSEcCtD
Trabectedin—Hypersensitivity—Capecitabine—colon cancer	0.000146	0.0011	CcSEcCtD
Trabectedin—Nervous system disorder—Methotrexate—colon cancer	0.000144	0.00109	CcSEcCtD
Trabectedin—Thrombocytopenia—Methotrexate—colon cancer	0.000144	0.00109	CcSEcCtD
Trabectedin—Skin disorder—Methotrexate—colon cancer	0.000143	0.00108	CcSEcCtD
Trabectedin—Asthenia—Capecitabine—colon cancer	0.000142	0.00107	CcSEcCtD
Trabectedin—Anorexia—Methotrexate—colon cancer	0.00014	0.00106	CcSEcCtD
Trabectedin—Hypotension—Methotrexate—colon cancer	0.000137	0.00104	CcSEcCtD
Trabectedin—Diarrhoea—Capecitabine—colon cancer	0.000135	0.00102	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000134	0.00102	CcSEcCtD
Trabectedin—Insomnia—Methotrexate—colon cancer	0.000133	0.00101	CcSEcCtD
Trabectedin—Paraesthesia—Methotrexate—colon cancer	0.000132	0.001	CcSEcCtD
Trabectedin—Dyspnoea—Methotrexate—colon cancer	0.000131	0.000994	CcSEcCtD
Trabectedin—Dizziness—Capecitabine—colon cancer	0.000131	0.00099	CcSEcCtD
Trabectedin—Dyspepsia—Methotrexate—colon cancer	0.000129	0.000981	CcSEcCtD
Trabectedin—Decreased appetite—Methotrexate—colon cancer	0.000128	0.000969	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000127	0.000962	CcSEcCtD
Trabectedin—Fatigue—Methotrexate—colon cancer	0.000127	0.000961	CcSEcCtD
Trabectedin—Vomiting—Capecitabine—colon cancer	0.000126	0.000952	CcSEcCtD
Trabectedin—Rash—Capecitabine—colon cancer	0.000125	0.000944	CcSEcCtD
Trabectedin—Dermatitis—Capecitabine—colon cancer	0.000124	0.000943	CcSEcCtD
Trabectedin—Headache—Capecitabine—colon cancer	0.000124	0.000938	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methotrexate—colon cancer	0.00012	0.000912	CcSEcCtD
Trabectedin—Nausea—Capecitabine—colon cancer	0.000117	0.000889	CcSEcCtD
Trabectedin—Abdominal pain—Methotrexate—colon cancer	0.000116	0.000881	CcSEcCtD
Trabectedin—Body temperature increased—Methotrexate—colon cancer	0.000116	0.000881	CcSEcCtD
Trabectedin—Hypersensitivity—Methotrexate—colon cancer	0.000108	0.000821	CcSEcCtD
Trabectedin—Asthenia—Methotrexate—colon cancer	0.000106	0.0008	CcSEcCtD
Trabectedin—Diarrhoea—Methotrexate—colon cancer	0.000101	0.000763	CcSEcCtD
Trabectedin—Dizziness—Methotrexate—colon cancer	9.73e-05	0.000737	CcSEcCtD
Trabectedin—Vomiting—Methotrexate—colon cancer	9.35e-05	0.000709	CcSEcCtD
Trabectedin—Rash—Methotrexate—colon cancer	9.27e-05	0.000703	CcSEcCtD
Trabectedin—Dermatitis—Methotrexate—colon cancer	9.26e-05	0.000702	CcSEcCtD
Trabectedin—Headache—Methotrexate—colon cancer	9.21e-05	0.000698	CcSEcCtD
Trabectedin—Nausea—Methotrexate—colon cancer	8.74e-05	0.000662	CcSEcCtD
Trabectedin—SRC—PDGFR-beta signaling pathway—PIK3CA—colon cancer	4.93e-05	0.00069	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—HRAS—colon cancer	4.87e-05	0.000683	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—KRAS—colon cancer	4.87e-05	0.000682	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—AKT1—colon cancer	4.81e-05	0.000674	CbGpPWpGaD
Trabectedin—SRC—Cell-Cell communication—PIK3CA—colon cancer	4.77e-05	0.000669	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	4.74e-05	0.000665	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—AKT1—colon cancer	4.74e-05	0.000663	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—NRAS—colon cancer	4.72e-05	0.000661	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—CDKN1A—colon cancer	4.69e-05	0.000658	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—NRAS—colon cancer	4.67e-05	0.000655	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—EGFR—colon cancer	4.64e-05	0.000649	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—NRAS—colon cancer	4.63e-05	0.000649	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—AKT1—colon cancer	4.63e-05	0.000648	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—EGFR—colon cancer	4.61e-05	0.000646	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—EGFR—colon cancer	4.61e-05	0.000646	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—NRAS—colon cancer	4.61e-05	0.000646	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—EGFR—colon cancer	4.59e-05	0.000643	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—colon cancer	4.56e-05	0.000639	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—HRAS—colon cancer	4.56e-05	0.000639	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—AKT1—colon cancer	4.56e-05	0.000638	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—VEGFA—colon cancer	4.51e-05	0.000632	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	4.49e-05	0.000629	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—PIK3CA—colon cancer	4.47e-05	0.000627	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ODC1—colon cancer	4.45e-05	0.000623	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CHST5—colon cancer	4.45e-05	0.000623	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CA7—colon cancer	4.41e-05	0.000618	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AXIN2—colon cancer	4.41e-05	0.000617	CbGpPWpGaD
Trabectedin—SRC—Immune System—BCL10—colon cancer	4.39e-05	0.000615	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—KRAS—colon cancer	4.38e-05	0.000614	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—KRAS—colon cancer	4.36e-05	0.000611	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—KRAS—colon cancer	4.36e-05	0.000611	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—KRAS—colon cancer	4.34e-05	0.000608	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—AKT1—colon cancer	4.3e-05	0.000603	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—EGFR—colon cancer	4.3e-05	0.000602	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—EGFR—colon cancer	4.26e-05	0.000597	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—EGFR—colon cancer	4.22e-05	0.000591	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—EGFR—colon cancer	4.2e-05	0.000589	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—NRAS—colon cancer	4.18e-05	0.000585	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—HRAS—colon cancer	4.14e-05	0.00058	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.13e-05	0.000579	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.12e-05	0.000578	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ODC1—colon cancer	4.09e-05	0.000573	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CHST5—colon cancer	4.09e-05	0.000573	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—HRAS—colon cancer	4.07e-05	0.00057	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—EGFR—colon cancer	4.06e-05	0.000569	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—KRAS—colon cancer	4.06e-05	0.000569	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ODC1—colon cancer	4.05e-05	0.000568	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CHST5—colon cancer	4.05e-05	0.000568	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.04e-05	0.000566	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—PIK3CA—colon cancer	4.02e-05	0.000564	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—KRAS—colon cancer	4.02e-05	0.000564	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—PIK3CA—colon cancer	4e-05	0.000561	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—VEGFA—colon cancer	4e-05	0.00056	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—KRAS—colon cancer	3.99e-05	0.000559	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—PIK3CA—colon cancer	3.98e-05	0.000558	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—KRAS—colon cancer	3.97e-05	0.000556	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD8A—colon cancer	3.97e-05	0.000556	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—AKT1—colon cancer	3.85e-05	0.00054	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—CASP3—colon cancer	3.83e-05	0.000537	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.82e-05	0.000535	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—EGFR—colon cancer	3.81e-05	0.000533	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—PIK3CA—colon cancer	3.73e-05	0.000523	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—HRAS—colon cancer	3.72e-05	0.000522	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—HRAS—colon cancer	3.7e-05	0.000519	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—HRAS—colon cancer	3.7e-05	0.000519	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—PIK3CA—colon cancer	3.7e-05	0.000518	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—HRAS—colon cancer	3.69e-05	0.000516	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—TGFB1—colon cancer	3.67e-05	0.000514	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—PIK3CA—colon cancer	3.66e-05	0.000513	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—AKT1—colon cancer	3.65e-05	0.000512	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—PIK3CA—colon cancer	3.65e-05	0.000511	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—CDKN1A—colon cancer	3.61e-05	0.000506	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—KRAS—colon cancer	3.6e-05	0.000504	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—AKT1—colon cancer	3.59e-05	0.000503	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—BCL2L1—colon cancer	3.53e-05	0.000495	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—PIK3CA—colon cancer	3.52e-05	0.000494	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.51e-05	0.000492	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—HRAS—colon cancer	3.45e-05	0.000483	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—HRAS—colon cancer	3.42e-05	0.000479	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.4e-05	0.000476	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—PPARG—colon cancer	3.39e-05	0.000475	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—HRAS—colon cancer	3.39e-05	0.000475	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—FGFR3—colon cancer	3.38e-05	0.000473	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—HRAS—colon cancer	3.37e-05	0.000473	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	3.3e-05	0.000463	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—AKT1—colon cancer	3.29e-05	0.00046	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—AKT1—colon cancer	3.27e-05	0.000458	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—AKT1—colon cancer	3.27e-05	0.000458	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—HRAS—colon cancer	3.26e-05	0.000457	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—AKT1—colon cancer	3.25e-05	0.000456	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—FGFR3—colon cancer	3.24e-05	0.000455	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—NRAS—colon cancer	3.21e-05	0.00045	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.18e-05	0.000446	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	3.12e-05	0.000437	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	3.06e-05	0.000428	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—AKT1—colon cancer	3.05e-05	0.000427	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—AKT1—colon cancer	3.02e-05	0.000423	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—AKT1—colon cancer	2.99e-05	0.000419	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—AKT1—colon cancer	2.98e-05	0.000417	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—VEGFA—colon cancer	2.94e-05	0.000412	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—colon cancer	2.93e-05	0.00041	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—NRAS—colon cancer	2.91e-05	0.000407	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—AKT1—colon cancer	2.88e-05	0.000403	CbGpPWpGaD
Trabectedin—SRC—Membrane Trafficking—AKT1—colon cancer	2.88e-05	0.000403	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.87e-05	0.000402	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—KRAS—colon cancer	2.77e-05	0.000387	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDH1—colon cancer	2.74e-05	0.000384	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	2.7e-05	0.000378	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ODC1—colon cancer	2.67e-05	0.000375	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CHST5—colon cancer	2.67e-05	0.000375	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—colon cancer	2.65e-05	0.000371	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—AKT1—colon cancer	2.55e-05	0.000357	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PIK3CA—colon cancer	2.54e-05	0.000356	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.5e-05	0.000351	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—KRAS—colon cancer	2.5e-05	0.000351	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD8A—colon cancer	2.41e-05	0.000337	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CTNNB1—colon cancer	2.39e-05	0.000334	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—colon cancer	2.35e-05	0.000329	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EP300—colon cancer	2.22e-05	0.000311	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—EP300—colon cancer	2.18e-05	0.000305	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—colon cancer	2.13e-05	0.000298	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CTNNB1—colon cancer	2.11e-05	0.000295	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—VEGFA—colon cancer	2.1e-05	0.000294	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.08e-05	0.000292	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKT1—colon cancer	2.08e-05	0.000291	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NRAS—colon cancer	2.08e-05	0.000291	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VEGFA—colon cancer	2.06e-05	0.000289	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CDKN1A—colon cancer	2.06e-05	0.000288	CbGpPWpGaD
Trabectedin—SRC—Immune System—BCL2L1—colon cancer	2.06e-05	0.000288	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ABCB1—colon cancer	2.04e-05	0.000285	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NRAS—colon cancer	2.04e-05	0.000285	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—TYMS—colon cancer	2e-05	0.00028	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDKN1A—colon cancer	1.98e-05	0.000277	CbGpPWpGaD
Trabectedin—SRC—Immune System—FGFR3—colon cancer	1.97e-05	0.000276	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EP300—colon cancer	1.96e-05	0.000274	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TGFB1—colon cancer	1.93e-05	0.00027	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TGFB1—colon cancer	1.89e-05	0.000265	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—colon cancer	1.89e-05	0.000265	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.84e-05	0.000257	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NRAS—colon cancer	1.83e-05	0.000257	CbGpPWpGaD
Trabectedin—SRC—Disease—FGFR3—colon cancer	1.82e-05	0.000255	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—KRAS—colon cancer	1.79e-05	0.00025	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NRAS—colon cancer	1.76e-05	0.000247	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—KRAS—colon cancer	1.75e-05	0.000245	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.67e-05	0.000234	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—colon cancer	1.67e-05	0.000234	CbGpPWpGaD
Trabectedin—SRC—Disease—APC—colon cancer	1.67e-05	0.000234	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDH1—colon cancer	1.66e-05	0.000233	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PIK3CA—colon cancer	1.61e-05	0.000226	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—colon cancer	1.6e-05	0.000225	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KRAS—colon cancer	1.58e-05	0.000221	CbGpPWpGaD
Trabectedin—SRC—Disease—BRAF—colon cancer	1.57e-05	0.00022	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—colon cancer	1.56e-05	0.000218	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.54e-05	0.000216	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ABCB1—colon cancer	1.52e-05	0.000213	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—colon cancer	1.52e-05	0.000213	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—colon cancer	1.51e-05	0.000212	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TYMS—colon cancer	1.5e-05	0.00021	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—colon cancer	1.49e-05	0.000209	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CA—colon cancer	1.45e-05	0.000203	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.44e-05	0.000202	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PPARG—colon cancer	1.42e-05	0.000199	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CA—colon cancer	1.39e-05	0.000195	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—colon cancer	1.34e-05	0.000188	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—colon cancer	1.34e-05	0.000188	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.32e-05	0.000184	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—colon cancer	1.32e-05	0.000184	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—colon cancer	1.29e-05	0.00018	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGFR3—colon cancer	1.27e-05	0.000178	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—colon cancer	1.27e-05	0.000177	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—colon cancer	1.23e-05	0.000172	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.2e-05	0.000168	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1A—colon cancer	1.2e-05	0.000168	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—colon cancer	1.18e-05	0.000166	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCB1—colon cancer	1.17e-05	0.000165	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—APC—colon cancer	1.17e-05	0.000164	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMS—colon cancer	1.15e-05	0.000162	CbGpPWpGaD
Trabectedin—SRC—Immune System—EP300—colon cancer	1.14e-05	0.00016	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—colon cancer	1.14e-05	0.000159	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—colon cancer	1.13e-05	0.000159	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—colon cancer	1.12e-05	0.000156	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1A—colon cancer	1.11e-05	0.000155	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BRAF—colon cancer	1.1e-05	0.000154	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.09e-05	0.000153	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCB1—colon cancer	1.08e-05	0.000151	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCB1—colon cancer	1.07e-05	0.00015	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—colon cancer	1.07e-05	0.00015	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMS—colon cancer	1.06e-05	0.000149	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PPARG—colon cancer	1.06e-05	0.000148	CbGpPWpGaD
Trabectedin—SRC—Disease—EP300—colon cancer	1.05e-05	0.000148	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMS—colon cancer	1.05e-05	0.000147	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—colon cancer	9.86e-06	0.000138	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—colon cancer	9.73e-06	0.000136	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—EP300—colon cancer	9.28e-06	0.00013	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—colon cancer	9.19e-06	0.000129	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—colon cancer	9.18e-06	0.000129	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—colon cancer	9.16e-06	0.000128	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—colon cancer	8.98e-06	0.000126	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.88e-06	0.000124	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—colon cancer	8.48e-06	0.000119	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—colon cancer	8.44e-06	0.000118	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—colon cancer	8.33e-06	0.000117	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—colon cancer	8.23e-06	0.000115	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PPARG—colon cancer	8.17e-06	0.000115	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.1e-06	0.000113	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—colon cancer	8.01e-06	0.000112	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—colon cancer	7.94e-06	0.000111	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—colon cancer	7.81e-06	0.000109	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—colon cancer	7.79e-06	0.000109	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1A—colon cancer	7.75e-06	0.000109	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PPARG—colon cancer	7.52e-06	0.000105	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PPARG—colon cancer	7.45e-06	0.000104	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EP300—colon cancer	7.38e-06	0.000103	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—colon cancer	7.21e-06	0.000101	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCB1—colon cancer	7.07e-06	9.9e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—colon cancer	6.99e-06	9.79e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMS—colon cancer	6.94e-06	9.72e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—EP300—colon cancer	6.93e-06	9.71e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—colon cancer	6.9e-06	9.67e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—colon cancer	6.9e-06	9.66e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—colon cancer	6.86e-06	9.61e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—colon cancer	6.43e-06	9.01e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—colon cancer	6.43e-06	9.01e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—colon cancer	6.41e-06	8.98e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—colon cancer	6.37e-06	8.92e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—colon cancer	6.29e-06	8.81e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—colon cancer	5.94e-06	8.32e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—colon cancer	5.91e-06	8.29e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—colon cancer	5.86e-06	8.21e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—colon cancer	5.61e-06	7.85e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—colon cancer	5.46e-06	7.65e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—EP300—colon cancer	5.35e-06	7.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—colon cancer	5.28e-06	7.4e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—colon cancer	5.13e-06	7.18e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—colon cancer	5.05e-06	7.07e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—EP300—colon cancer	4.92e-06	6.89e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPARG—colon cancer	4.92e-06	6.89e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—EP300—colon cancer	4.88e-06	6.83e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—colon cancer	4.46e-06	6.25e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—colon cancer	4.19e-06	5.87e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—colon cancer	3.96e-06	5.54e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—colon cancer	3.87e-06	5.42e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—colon cancer	3.64e-06	5.1e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—colon cancer	3.61e-06	5.05e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—colon cancer	3.23e-06	4.53e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—EP300—colon cancer	3.22e-06	4.51e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—colon cancer	2.97e-06	4.16e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—colon cancer	2.95e-06	4.13e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—colon cancer	2.38e-06	3.33e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—colon cancer	1.94e-06	2.72e-05	CbGpPWpGaD
